Literature DB >> 29403012

A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism.

Fabio L Fernandes-Rosa1,2,3, Georgios Daniil4,5, Ian J Orozco6,7, Corinna Göppner6,7, Rami El Zein4,5, Vandana Jain8, Sheerazed Boulkroun4,5, Xavier Jeunemaitre4,5,9, Laurence Amar4,5,10, Hervé Lefebvre11,12,13, Thomas Schwarzmayr14, Tim M Strom14,15, Thomas J Jentsch16,17, Maria-Christina Zennaro18,19,20.   

Abstract

Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel 1 , in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl- currents that were abolished in Clcn2-/- mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain'2,3, abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl- conductance at resting potentials. Expression of ClC-2Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29403012     DOI: 10.1038/s41588-018-0053-8

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  43 in total

1.  Regions involved in the opening of CIC-2 chloride channel by voltage and cell volume.

Authors:  S Gründer; A Thiemann; M Pusch; T J Jentsch
Journal:  Nature       Date:  1992 Dec 24-31       Impact factor: 49.962

2.  A chloride channel widely expressed in epithelial and non-epithelial cells.

Authors:  A Thiemann; S Gründer; M Pusch; T J Jentsch
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

3.  Molecular dissection of gating in the ClC-2 chloride channel.

Authors:  S E Jordt; T J Jentsch
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

Review 4.  Prevalence of primary aldosteronism in patient's cohorts and in population-based studies--a review of the current literature.

Authors:  A Hannemann; H Wallaschofski
Journal:  Horm Metab Res       Date:  2011-12-01       Impact factor: 2.936

5.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

Review 6.  Hyperaldosteronism as a common cause of resistant hypertension.

Authors:  David A Calhoun
Journal:  Annu Rev Med       Date:  2012-10-22       Impact factor: 13.739

7.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

8.  Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.

Authors:  Sébastien Savard; Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

Review 9.  Genetic Causes of Functional Adrenocortical Adenomas.

Authors:  Maria-Christina Zennaro; Sheerazed Boulkroun; Fabio Fernandes-Rosa
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

10.  Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants.

Authors: 
Journal:  Lancet       Date:  2016-11-16       Impact factor: 79.321

View more
  59 in total

1.  Na/K Pump Mutations Associated with Primary Hyperaldosteronism Cause Loss of Function.

Authors:  Dylan J Meyer; Craig Gatto; Pablo Artigas
Journal:  Biochemistry       Date:  2019-03-14       Impact factor: 3.162

Review 2.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 3.  [Primary aldosteronism : Genetics and pathology].

Authors:  U Scholl
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

Review 4.  Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels.

Authors:  Michael Stowasser; Martin Wolley; Aihua Wu; Richard D Gordon; Julia Schewe; Gabriel Stölting; Ute I Scholl
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

5.  Molecular and Electrophysiological Analyses of ATP2B4 Gene Variants in Bilateral Adrenal Hyperaldosteronism.

Authors:  Namita Ganesh Hattangady; Jessica Foster; Antonio Marcondes Lerario; Daniela Ponce-Balbuena; Juilee Rege; Silvia Monticone; William E Rainey; Paolo Mulatero; Tobias Else
Journal:  Horm Cancer       Date:  2020-01-30       Impact factor: 3.869

6.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 7.  Hereditary causes of primary aldosteronism and other disorders of apparent excess mineralocorticoid activity.

Authors:  Xin He; Zubin Modi; Tobias Else
Journal:  Gland Surg       Date:  2020-02

Review 8.  Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Koshiro Nishimoto
Journal:  Horm Metab Res       Date:  2020-04-14       Impact factor: 2.936

Review 9.  Primary Aldosteronism: Practical Approach to Diagnosis and Management.

Authors:  James Brian Byrd; Adina F Turcu; Richard J Auchus
Journal:  Circulation       Date:  2018-08-21       Impact factor: 29.690

10.  Knockout of ClC-2 reveals critical functions of adherens junctions in colonic homeostasis and tumorigenicity.

Authors:  Younggeon Jin; Dina Ibrahim; Scott T Magness; Anthony T Blikslager
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-04       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.